Filing metadata

Accession number
0001193125-26-023089
Form type
Form 3
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Jan 26, 2026
Reporting period
Jan 05, 2026
Description
Initial ownership

Explore SEC Filings Hub